NB-402

N/A

Report date: 2023/02/18 19:47:18

Base Information

Drug NameNB-402
Drug Alias NameNB-402
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus internalization inhibitors
TargetsUpdating
Therapy Area/IndicationsRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBluewillow Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNanobio Co
Active IndicationsN/A
Inactive IndicationsRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A